Forex News
Breaking News: Milestone Scientific Inc. Makes a Splash with $3.0 Million Public Offering of Common Stock!
Exciting News from Milestone Scientific Inc. December 10, 2023 Roseland, New Jersey Hey there, fellow injection enthusiasts! Have you heard the latest news from Milestone Scientific Inc.? If not, you’re in for a treat! Today, the company announced the pricing of an underwritten public offering of 4,765,000 shares of its common stock at a price…
Secure Your Investment: Rosen, a Trusted Firm, Urges SCYNEXIS Inc. Investors to Seek Counsel Before Securities Class Action Deadline
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action NEW YORK, Dec. 10, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SCYNEXIS, Inc. (NASDAQ: SCYX) between March 31, 2023 and September 22, 2023,…
Rosen Investor Counsel Urges Beauty & Health Company Investors to Seek Legal Guidance Before Securities Class Action Deadline
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Beauty Health Company Investors to Secure Counsel Before Important Deadline in Securities Class Action NEW YORK, Dec. 10, 2023 (GLOBE NEWSWIRE) — ROSEN Law Firm, a global investor rights law firm, reminds purchasers of securities of The Beauty Health Company (NASDAQ: SKIN) between May 10, 2022 and November 13,…
Unlocking the Potential: FibroGen’s Groundbreaking Findings from the Phase 3 Matterhorn Trial of Roxadustat at the American Society of Hematology Annual Meeting
FibroGen Presents Data from Phase 3 MATTERHORN Trial of Roxadustat A Groundbreaking Study in Anemia Treatment A recent post hoc analysis of data from the Phase 3 MATTERHORN trial has revealed exciting results for patients with anemia of lower risk transfusion-dependent. The study focused on the efficacy of roxadustat compared to a placebo in achieving…
Get Ready to Conquer the Forex World: Your Ultimate EUR/JPY Weekly Forecast!
EUR/JPY Weekly Outlook The Rollercoaster Ride of EUR/JPY Oh, the wild ride that is EUR/JPY! Last week, the pair’s decline from 164.29 hit a low of 153.15 before making a recovery. Just when things seemed bleak, EUR/JPY managed to bounce back after breaking through the 154.32 cluster support. Talk about a comeback! What’s Next for…
2024 Stock Market Forecast: Expert Reveals Bold Predictions for the Year Ahead!
The Year Ahead: What to Expect from the Stock Market in 2024 Tom Lee Predicts a Bullish Future for the S&P 500 The S&P 500 is expected to reach new heights by the end of 2024, according to Tom Lee, head of research at Fundstrat Global Advisors. Lee predicts that the index will rally to…
Attention Investors: Recover Your Losses with the Portnoy Law Firm – A Guide to Microvast Holdings Inc. Deadline on February 5, 2024
Attention Investors: Recover Your Losses with the Portnoy Law Firm – A Guide to Microvast Holdings Inc. Deadline on February 5, 2024. Description: Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Dec. 08, 2023 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Microvast Holdings, Inc….
Revolutionizing Cancer Treatment: Opto-Acoustic Imaging Proven to Predict Pathologic Response During Neoadjuvant Therapy
Study Finds Opto-Acoustic Imaging During Neoadjuvant Therapy Correlates to Pathologic Response Introduction A recent study presented at the San Antonio Breast Cancer Symposium (SABCS) has shed light on the potential of Seno Medical’s Imagio® Breast Imaging System to detect response earlier during breast cancer therapy. The study focused on the use of opto-acoustic/ultrasound (OA/US) technology,…